Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis BROOKS

Max Ratio

Dividend Yield

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History BROOKS

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – INR
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth BROOKS

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin BROOKS

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income BROOKS

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM BROOKS

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio BROOKS

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Brooks Laboratories Limited BROOKS

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself BROOKS

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 21.11
Forward PE
Enterprise Value Revenue 3.36
Price Sales TTM 3.15
Enterprise Value EBITDA 18.67
Price Book MRQ 2.60

Brooks Laboratories Limited Dividends: – Yield, History, Payment Schedule

BROOKS
Current price
98.50 INR -0.38 INR (-0.38%)
Last closed 98.88 INR
ISIN INE650L01011
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange National Stock Exchange of India
Capitalization 2 908 192 349 INR
Yield for 12 month -27.57 %
1Y
3Y
5Y
10Y
15Y
BROOKS
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+821 725 236 INR

Last Year

+791 160 191 INR

Current Quarter

+233 415 466 INR

Last Quarter

+253 931 465 INR

Current Year

+138 571 002 INR

Last Year

+224 082 074 INR

Current Quarter

+96 938 662 INR

Last Quarter

+95 746 234 INR
EBITDA 87 654 088 INR
Operating Margin TTM 9.09 %
Price to Earnings 21.11
Return On Assets TTM 4.10 %
PEG Ratio
Return On Equity TTM 15.98 %
Wall Street Target Price 4 756.07 INR
Revenue TTM 923 624 682 INR
Book Value 39.11 INR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 12.80 %
Dividend Yield
Gross Profit TTM 339 142 007 INR
Earnings per share 4.65 INR
Diluted Eps TTM 4.65 INR
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY
Profit Margin 15.06 %

Technical Indicators BROOKS

For 52 Weeks

94.81 INR 197.93 INR
50 Day MA 116.15 INR
Shares Short Prior Month
200 Day MA 130.52 INR
Short Ratio
Shares Short
Short Percent